Bethanechol ( DrugBank: Bethanechol )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 98 | Eosinophilic gastrointestinal disease | 1 |
98. Eosinophilic gastrointestinal disease
Clinical trials : 172 / Drugs : 149 - (DrugBank : 39) / Drug target genes : 38 - Drug target pathways : 135
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02058537 (ClinicalTrials.gov) | February 2014 | 4/2/2014 | Bethanechol for Eosinophilic Esophagitis | Bethanechol for Treatment of Eosinophilic Esophagitis (EoE) | Eosinophilic Esophagitis (EoE) | Drug: Bethanechol | University of Iowa | NULL | Terminated | 18 Years | 75 Years | All | 2 | Phase 2 | United States |